MSOS Weekly Review | Jul 6–10, 2026

MSOS softened during the review week as investors continued to treat policy headlines cautiously until liquidity and breadth confirm a firmer tone.

MSOS declined about -1.10% during the review week and remains roughly 20.05% above its three-month low.

Participation remained mixed, with breadth and trading activity not yet confirming a broader advance.

DEA scheduling developments continued to move forward, although market reaction remained limited.

Key Takeaways

• MSOS finished lower over Jul 6, 2026 – Jul 10, 2026.
• Participation remained mixed, with breadth and trading activity not yet confirming a broader advance.
• DEA scheduling developments continued to move forward, although market reaction remained limited.

MSOS declined about -1.10% over Jul 6, 2026 – Jul 10, 2026, keeping attention on whether recent support can hold without broader participation.

Price remains roughly 20.05% above its three-month low, leaving the chart focused on whether the group can convert policy optimism into sustained institutional accumulation.

Participation was modestly positive, with advancers slightly outnumbering decliners. Breadth remained mixed, with fewer than half of tracked names above short- and intermediate-term trend measures. Liquidity was subdued, with average volume slightly lower, spreads relatively contained, and volatility moderate.

DEA activity dominated cannabis policy discussion last week, with the agency advancing participant selection for the Schedule III rescheduling process. The market relevance is procedural: investors are tracking whether the hearing process can produce a clearer final-rule timeline for major U.S. operators.

The market response remained muted, suggesting investors are still discounting procedural DEA steps until a clearer final-rule timeline emerges.

State-level developments in Texas and New York remained active, though most appear unlikely to materially change near-term earnings expectations for major U.S. operators.

MSOS remains well above its three-month low but below the upper end of its three-month range. Relative strength remained concentrated in MSOS and TLRY, while SNDL continued to lag. Leadership remains narrow rather than broadly constructive.

Overall posture: Defensive

Next week’s tape will likely be shaped by whether policy headlines, breadth, and liquidity begin to confirm the recent stabilization.

• Monitor whether MSOS can sustain closes above key moving averages after the latest weekly gain.
• Watch whether advancers begin to outnumber decliners by a wider margin across the tracked universe.
• Track whether dollar volume expands alongside price gains or fades into thinner trading conditions.
• Follow developments from the DEA hearing and any scheduling, banking, or tax-related federal updates.
• Track operator financing, guidance revisions, earnings updates, and exchange-related announcements for changes in relative strength leadership.
• DEA scheduling developments — whether policy momentum becomes investable confirmation rather than procedural background